Skip to main content
bioMérieux logo

bioMérieux — Investor Relations & Filings

Ticker · BIM ISIN · FR0013280286 LEI · 549300AK8Y0LBIQ4T071 PA Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2020-07-09 Earnings Release
Country FR France
Listing PA BIM

About bioMérieux

https://www.biomerieux.com/

bioMérieux is a global leader in the field of in vitro diagnostics, providing solutions that determine the source of disease and contamination. The company develops and manufactures diagnostic systems, reagents, and software for both clinical and industrial applications. In the clinical sector, its products are used for diagnosing infectious diseases, managing sepsis, combating antimicrobial resistance, and supporting cancer screening and cardiovascular emergencies. For industrial markets, bioMérieux offers microbiological control solutions to ensure the safety and quality of agri-food, pharmaceutical, and cosmetic products. These technologies provide rapid and reliable data to help healthcare professionals and industrial quality control managers make critical decisions that improve patient outcomes and ensure consumer safety.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Earnings Release Classification · 98% confidence The document is titled "bioMérieux – Préannonce de la performance commerciale du 2e trimestre 2020" (bioMérieux – Preliminary announcement of commercial performance for the 2nd quarter 2020). It provides preliminary revenue figures for the first half of 2020 and the second quarter of 2020, highlighting key performance drivers and mentioning a financing event (Euro PP issuance). Crucially, it states: "Le détail du chiffre d'affaires du 2e trimestre ainsi que les résultats financiers du premier semestre seront publiés le 2 septembre 2020." This indicates the document is an early release of key financial highlights before the full, detailed report (which would likely be an IR or MDA). This fits the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), as the detailed results are explicitly scheduled for a later date. H1 2020
2020-07-09 French
Inside Information / Other news releases
Earnings Release Classification · 98% confidence The document is titled "bioMérieux – Second-Quarter 2020 Business Performance Preannouncement" and explicitly states it is announcing "preliminary quarterly information about its business activity ending June 30, 2020." It provides key financial metrics (sales figures, growth rates) for the second quarter and the first half of 2020. This content structure—a preannouncement of periodic financial results—aligns perfectly with the definition of an Earnings Release (ER). Although it mentions that detailed information will be released on September 2, 2020, the document itself contains the core earnings highlights, making ER the most appropriate classification over RPA (Report Publication Announcement). H1 2020
2020-07-09 English
Acquisition or disposal of the issuer's own shares / Description of the buyback program
Transaction in Own Shares Classification · 98% confidence The document explicitly details the 'DESCRIPTION OF THE NEW SHARE BUYBACK PROGRAM PURSUANT TO ARTICLE 241-1 TO ARTICLE 241-6 OF THE AMF GENERAL REGULATIONS' and discusses the implementation of this program authorized by the Annual General Meeting. Key elements include the maximum stake, purchase price, objectives (liquidity, hedging stock options, capital reduction, acquisitions), and the term of the program. This content directly relates to the company's plans for acquiring or disposing of its own shares, which falls under the definition of 'Transaction in Own Shares' (POS). It is not a general financing update (CAP) but a specific report on share repurchase mechanics.
2020-06-30 English
Acquisition ou cession des actions de l'émetteur / Descriptif du programme de rachat
Transaction in Own Shares Classification · 98% confidence The document is titled "DESCRIPTIF DU PROGRAMME DE RACHAT D'ACTIONS" (Description of the Share Buyback Program) and details the authorization, objectives (liquidity, employee stock plans, capital reduction), maximum price, and duration of a share repurchase program authorized by the General Meeting of June 30, 2020. This content directly relates to the company's actions regarding its own shares, specifically repurchases. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). It is not a general earnings release (ER), a full annual report (10-K), or a simple announcement of a report (RPA), but the detailed description of the buyback mechanism itself.
2020-06-30 French
Inside Information / Other news releases
Capital/Financing Update Classification · 99% confidence The document is a press release dated June 29, 2020, announcing that bioMérieux has successfully issued a €200 million Euro PP bond (a form of debt financing). It details the tranches, coupon, purpose (extending maturity, refinancing existing debt), and advisors involved. This content directly relates to the company's fundraising and capital structure activities. Based on the provided definitions, this aligns perfectly with the 'Capital/Financing Update' category.
2020-06-29 English
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 99% confidence The document is a press release dated June 29, 2020, announcing that bioMérieux has successfully issued a new 200 million euro Euro PP bond. The text details the structure (two tranches, maturities, coupon rate), the purpose (extending debt maturity, general corporate needs, refinancing 2013 debt), and the advisors involved. This clearly falls under the category of financing activities and capital structure changes, matching the definition for 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate finance transaction.
2020-06-29 French

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.